Exhibit 23.3
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2011 Equity Incentive Plan of Jazz Pharmaceuticals plc (the Successor) of our report dated February 28, 2012, with respect to the consolidated balance sheet of Jazz Pharmaceuticals, Inc. (the Predecessor) and its subsidiaries as of December 31, 2011, the related consolidated statements of income, comprehensive income, stockholders’ equity (deficit), and cash flows for each of the two years in the period ended December 31, 2011, and the related financial statement schedule for 2011 and 2010, included in the Annual Report (Form 10-K) of Jazz Pharmaceuticals plc for the year ended December 31, 2012.
/s/ Ernst & Young LLP
Redwood City, California
February 26, 2013